{"url_path":"/sec/bglc/8-k/2026-06-05/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statement and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1737523/0001477932-26-003658-index.html","accession_number":"0001477932-26-003658","cik":"0001737523","ticker":"BGLC","issuer_name":"BioNexus Gene Lab Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737523/0001477932-26-003658-index.html","primary_entity_key":"0001737523","primary_entity_name":"BioNexus Gene Lab Corp"},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statement and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit No.**\n\n \n\n**Description**\n\n[99.1](bglc_ex991.htm)\n\n \n\n[Press Release dated May 29, 2026](bglc_ex991.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n**BioNexus Gene Lab Corp.**\n\n \n\nBy:\n\n*/s/ Su-Leng Tan Lee*\n\n \n\n \n\nSu-Leng Tan Lee\n\n \n\n \n\nChief Executive Officer\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 5, 2026\n\n \n\n \n\n \n\n3"}